Alan B. Sandler's most recent trade in Elevation Oncology Inc was a trade of 35,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elevation Oncology Inc | Alan B. Sandler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Alx Oncology Holdings Inc | Alan B. Sandler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Apr 2025 | 125,000 | 125,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Alan B. Sandler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Alan B. Sandler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2024 | 600,000 | 600,000 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Alan B. Sandler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 40,400 | 40,400 | - | - | Stock Option (right to buy) | |
| Elevation Oncology Inc | Alan B. Sandler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 35,000 | 35,000 | - | - | Stock Option (Right to Buy) | |
| Elevation Oncology Inc | Alan B. Sandler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| Mirati Therapeutics Inc | Alan B. Sandler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 37.00 per share. | 09 Aug 2023 | 22,297 | 62,297 (0%) | 0% | 37 | 824,989 | Common Stock |
| Mirati Therapeutics Inc | Alan B. Sandler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 65,000 | 65,000 | - | - | Stock Option (Right to buy) | |
| Mirati Therapeutics Inc | Alan B. Sandler | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 40,000 | 40,000 (0%) | 0% | 0 | Common Stock |